These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 27796284)

  • 1. Modulation of host signaling in the inflammatory response by enteropathogenic Escherichia coli virulence proteins.
    Zhuang X; Chen Z; He C; Wang L; Zhou R; Yan D; Ge B
    Cell Mol Immunol; 2017 Mar; 14(3):237-244. PubMed ID: 27796284
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulation of the Inflammasome Signaling Pathway by Enteropathogenic and Enterohemorrhagic Escherichia coli.
    Yen H; Karino M; Tobe T
    Front Cell Infect Microbiol; 2016; 6():89. PubMed ID: 27617233
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of NF-κB signaling in human dendritic cells by the enteropathogenic Escherichia coli effector protein NleE.
    Vossenkämper A; Marchès O; Fairclough PD; Warnes G; Stagg AJ; Lindsay JO; Evans PC; Luong le A; Croft NM; Naik S; Frankel G; MacDonald TT
    J Immunol; 2010 Oct; 185(7):4118-27. PubMed ID: 20833837
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bringing down the host: enteropathogenic and enterohaemorrhagic Escherichia coli effector-mediated subversion of host innate immune pathways.
    Santos AS; Finlay BB
    Cell Microbiol; 2015 Mar; 17(3):318-32. PubMed ID: 25588886
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dynamics of expression, secretion and translocation of type III effectors during enteropathogenic Escherichia coli infection.
    Serapio-Palacios A; Finlay BB
    Curr Opin Microbiol; 2020 Apr; 54():67-76. PubMed ID: 32058947
    [TBL] [Abstract][Full Text] [Related]  

  • 6. EspFu-Mediated Actin Assembly Enhances Enteropathogenic
    Martins FH; Kumar A; Abe CM; Carvalho E; Nishiyama-Jr M; Xing C; Sperandio V; Elias WP
    mBio; 2020 Apr; 11(2):. PubMed ID: 32291304
    [TBL] [Abstract][Full Text] [Related]  

  • 7. EspZ of enteropathogenic and enterohemorrhagic Escherichia coli regulates type III secretion system protein translocation.
    Berger CN; Crepin VF; Baruch K; Mousnier A; Rosenshine I; Frankel G
    mBio; 2012; 3(5):. PubMed ID: 23033475
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The NleE/OspZ family of effector proteins is required for polymorphonuclear transepithelial migration, a characteristic shared by enteropathogenic Escherichia coli and Shigella flexneri infections.
    Zurawski DV; Mumy KL; Badea L; Prentice JA; Hartland EL; McCormick BA; Maurelli AT
    Infect Immun; 2008 Jan; 76(1):369-79. PubMed ID: 17984206
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulation of Host Cell Processes by T3SS Effectors.
    Shenoy AR; Furniss RCD; Goddard PJ; Clements A
    Curr Top Microbiol Immunol; 2018; 416():73-115. PubMed ID: 30178263
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel Host Proteins and Signaling Pathways in Enteropathogenic E. coli Pathogenesis Identified by Global Phosphoproteome Analysis.
    Scholz R; Imami K; Scott NE; Trimble WS; Foster LJ; Finlay BB
    Mol Cell Proteomics; 2015 Jul; 14(7):1927-45. PubMed ID: 25944883
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Salmonella, E. coli, and Citrobacter Type III Secretion System Effector Proteins that Alter Host Innate Immunity.
    El Qaidi S; Wu M; Zhu C; Hardwidge PR
    Adv Exp Med Biol; 2019; 1111():205-218. PubMed ID: 30411307
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The type III secretion effector NleF of enteropathogenic Escherichia coli activates NF-κB early during infection.
    Pallett MA; Berger CN; Pearson JS; Hartland EL; Frankel G
    Infect Immun; 2014 Nov; 82(11):4878-88. PubMed ID: 25183730
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NleC, a type III secretion protease, compromises NF-κB activation by targeting p65/RelA.
    Yen H; Ooka T; Iguchi A; Hayashi T; Sugimoto N; Tobe T
    PLoS Pathog; 2010 Dec; 6(12):e1001231. PubMed ID: 21187904
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Measuring Effector-Mediated Modulation of Inflammatory Responses to Infection with Enteropathogenic and Shiga Toxin-Producing E. coli.
    Pollock GL; Giogha C; Hartland EL
    Methods Mol Biol; 2021; 2291():317-332. PubMed ID: 33704761
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Host Cell Targeting by Enteropathogenic Bacteria T3SS Effectors.
    Pinaud L; Sansonetti PJ; Phalipon A
    Trends Microbiol; 2018 Apr; 26(4):266-283. PubMed ID: 29477730
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Attaching and effacing bacterial effector NleC suppresses epithelial inflammatory responses by inhibiting NF-κB and p38 mitogen-activated protein kinase activation.
    Sham HP; Shames SR; Croxen MA; Ma C; Chan JM; Khan MA; Wickham ME; Deng W; Finlay BB; Vallance BA
    Infect Immun; 2011 Sep; 79(9):3552-62. PubMed ID: 21746856
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extra! Extracellular Effector Delivery into Host Cells via the Type 3 Secretion System.
    Kendall MM
    mBio; 2017 May; 8(3):. PubMed ID: 28465427
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A type III effector antagonizes death receptor signalling during bacterial gut infection.
    Pearson JS; Giogha C; Ong SY; Kennedy CL; Kelly M; Robinson KS; Lung TW; Mansell A; Riedmaier P; Oates CV; Zaid A; Mühlen S; Crepin VF; Marches O; Ang CS; Williamson NA; O'Reilly LA; Bankovacki A; Nachbur U; Infusini G; Webb AI; Silke J; Strasser A; Frankel G; Hartland EL
    Nature; 2013 Sep; 501(7466):247-51. PubMed ID: 24025841
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mitochondrial Targeting of the Enteropathogenic Escherichia coli Map Triggers Calcium Mobilization, ADAM10-MAP Kinase Signaling, and Host Cell Apoptosis.
    Ramachandran RP; Spiegel C; Keren Y; Danieli T; Melamed-Book N; Pal RR; Zlotkin-Rivkin E; Rosenshine I; Aroeti B
    mBio; 2020 Sep; 11(5):. PubMed ID: 32934081
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tandem tyrosine phosphosites in the Enteropathogenic Escherichia coli chaperone CesT are required for differential type III effector translocation and virulence.
    Runte CS; Jain U; Getz LJ; Secord S; Kuwae A; Abe A; LeBlanc JJ; Stadnyk AW; Kaper JB; Hansen AM; Thomas NA
    Mol Microbiol; 2018 Jun; 108(5):536-550. PubMed ID: 29509331
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.